Mwanzo600535 • SHA
add
Tasly Pharmaceutical Group Co Ltd
Bei iliyotangulia
¥ 14.54
Bei za siku
¥ 14.57 - ¥ 14.81
Bei za mwaka
¥ 12.24 - ¥ 17.77
Thamani ya kampuni katika soko
22.05B CNY
Wastani wa hisa zilizouzwa
8.69M
Uwiano wa bei na mapato
25.11
Mgao wa faida
2.79%
Ubadilishanaji wa msingi
SHA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.09B | -4.06% |
Matumizi ya uendeshaji wa biashara | 1.03B | -2.03% |
Mapato halisi | 179.89M | -44.67% |
Kiwango cha faida halisi | 8.60 | -42.36% |
Mapato kwa kila hisa | — | — |
EBITDA | 441.72M | -18.76% |
Asilimia ya kodi ya mapato | 14.16% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 4.97B | 13.35% |
Jumla ya mali | 16.83B | -4.76% |
Jumla ya dhima | 3.82B | -22.94% |
Jumla ya hisa | 13.02B | — |
hisa zilizosalia | 1.49B | — |
Uwiano wa bei na thamani | 1.71 | — |
Faida inayotokana na mali | 4.92% | — |
Faida inayotokana mtaji | 5.52% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 179.89M | -44.67% |
Pesa kutokana na shughuli | 303.22M | 22.05% |
Pesa kutokana na uwekezaji | -260.81M | -362.16% |
Pesa kutokana na ufadhili | -992.53M | -2,032.67% |
Mabadiliko halisi ya pesa taslimu | -951.66M | -338.75% |
Mtiririko huru wa pesa | -824.52M | -1,070.21% |
Kuhusu
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Ilianzishwa
1994
Tovuti
Wafanyakazi
9,223
